{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:42:55Z","timestamp":1790030575250,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.ijrobp.2005.09.041","type":"journal-article","created":{"date-parts":[[2006,1,11]],"date-time":"2006-01-11T14:36:36Z","timestamp":1136990196000},"page":"983-994","source":"Crossref","is-referenced-by-count":117,"title":["French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin\/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC)"],"prefix":"10.1016","volume":"64","author":[{"given":"Ren\u00e9-Jean","family":"Bensadoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"B\u00e9n\u00e9zery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Dassonville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Magn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Poissonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Rama\u00efoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Lemanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Bourdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Tortochaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Peyrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Marcy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chamorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Vallicioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Seng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Alzieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"G\u00e9ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Chauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Demard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Calais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2005.09.041_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM199301213280306","article-title":"Head and neck cancer","volume":"328","author":"Vokes","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib3","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"18","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib4","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2005.07.010","article-title":"Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer","volume":"23","author":"Budach","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib5","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib6","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2003.08.036","article-title":"Hyperfractionated accelerated radiotherapy alone and with concomitant chemotherapy to the head and neck","volume":"58","author":"Hehr","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-0","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0360-3016(98)00235-1","article-title":"Concomitant b.i.d. radiotherapy and chemotherapy with cisplatin and 5-fluorouracil in unresectable squamous-cell carcinoma of the pharynx","volume":"42","author":"Bensadoun","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib9","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00001622-200405000-00004","article-title":"Altered fractionation radiotherapy in the management of head and neck carcinomas","volume":"16","author":"Bourhis","year":"2004","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib10","first-page":"28","article-title":"Cisplatin combinations in the treatment of head and neck cancer","volume":"21","author":"Al-Sarraf","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s005200050256","article-title":"Low-energy He\/Ne laser in the prevention of radiation-induced mucositis","volume":"7","author":"Bensadoun","year":"1999","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib12","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0360-3016(97)00076-X","article-title":"Low energy helium-neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant","volume":"38","author":"Cowen","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib14","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0360-3016(91)90670-Y","article-title":"Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in Stages III and IV oropharyngeal carcinoma","volume":"21","author":"Pinto","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib15","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ijrobp.2003.09.017","article-title":"Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience","volume":"58","author":"Allal","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/hed.2880150202","article-title":"Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck","volume":"15","author":"Parsons","year":"1993","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0360-3016(94)00334-H","article-title":"Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck","volume":"31","author":"Garden","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib18","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/sj.bjc.6690829","article-title":"A prospective quality of life in the CHART randomized trial in head and neck cancer","volume":"81","author":"Griffiths","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/hn.1999.v120.a90352","article-title":"Quality of life effects of psychosocial intervention in patients with head and neck cancer","volume":"120","author":"Hammerlid","year":"1999","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jnci\/85.2.95","article-title":"Overview of combined modality therapies for head and neck cancer","volume":"85","author":"Dimery","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1200\/JCO.2005.09.925","article-title":"Is there still a role for induction chemotherapy for head and neck cancer?","volume":"23","author":"Garden","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/1097-0142(19850301)55:5<1123::AID-CNCR2820550530>3.0.CO;2-8","article-title":"Improved complete response rate and survival in advanced head and neck cancer after three-course induction therapy with 120 hour 5FU infusion and Cisplatin","volume":"55","author":"Rooney","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/bjc.1986.237","article-title":"Induction chemotherapy with cis-platinum and 5-fluorouracil for squamous cell carcinoma of the head and neck","volume":"54","author":"Thyss","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib24","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1200\/JCO.1990.8.2.241","article-title":"Induction chemotherapy with cisplatin, fluorouracil, and high dose leucovorin for locally advanced head and neck cancer","volume":"8","author":"Vokes","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2214\/ajr.126.2.229","article-title":"Combined radiotherapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx","volume":"126","author":"Lo","year":"1976","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib26","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1200\/JCO.2000.18.7.1458","article-title":"Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck","volume":"18","author":"Jeremic","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib27","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1200\/JCO.1993.11.11.2136","article-title":"Concurrent radiation therapy and chemotherapy for locally unresectable squamous cell head and neck cancer","volume":"11","author":"Adelstein","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.canrad.2004.11.002","article-title":"Apport des m\u00e9ta-analyses sur donn\u00e9es individuelles au traitement des cancers ORL","volume":"9","author":"Pignon","year":"2005","journal-title":"Cancer Radioth\u00e9rapie"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib29","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/(SICI)1097-0142(19970715)80:2<266::AID-CNCR15>3.0.CO;2-S","article-title":"Hyperfractionated radiation therapy and 5-fluorouracil, cisplatin, and mitomycin-c (+\/- granulocyte-colony stimulating factor) in the treatment of patients with locally advanced head and neck carcinoma","volume":"80","author":"Abitbol","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib30","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1200\/JCO.1991.9.3.458","article-title":"Concurrent cisplatin, infusional fluorouracil, and conventionally fractionated radiation therapy in head and neck cancer","volume":"9","author":"Denham","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib31","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s004050100368","article-title":"Chemotherapy- and radiotherapy-induced mucositis in head and neck cancer patients","volume":"258","author":"Bensadoun","year":"2001","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s004050000311","article-title":"Comparison between nasogastric tube feeding and percutaneous fluoroscopic gastrostomy in advanced head and neck cancer patients","volume":"258","author":"Magn\u00e9","year":"2001","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib34","doi-asserted-by":"crossref","first-page":"S510","DOI":"10.1016\/j.ijrobp.2004.07.454","article-title":"Feeding tube placement facilitates aggressive hyperfractionated chemoradiation (HXCRT) for unresectable head and neck cancer","volume":"601","author":"Allen","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib35","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0360-3016(94)90205-4","article-title":"The importance of schedule and drug dose intensity in combinations of modalities","volume":"28","author":"Kallman","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib36","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1200\/JCO.1995.13.7.1656","article-title":"Phase II trial of cisplatin, fluorouracil, and pure l folinic acid for locally advanced head and neck cancer","volume":"13","author":"Schneider","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11912-005-0039-4","article-title":"Intensity-modulated radiotherapy","volume":"7","author":"Chambers","year":"2005","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib38","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hed.1095","article-title":"Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients","volume":"23","author":"Magn\u00e9","year":"2001","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib39","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0360-3016(03)01576-1","article-title":"Toxic cure","volume":"58","author":"Maguire","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib40","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.ijrobp.2003.09.004","article-title":"Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer","volume":"58","author":"Brizel","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib41","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/hed.20045","article-title":"Radiation-induced xerostomia in patients with head and neck cancer","volume":"26","author":"Chambers","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.joms.2003.08.009","article-title":"Risk of osteoradionecrosis after extraction of impacted third molars in irradiated head and neck cancer patients","volume":"62","author":"Oh","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0360-3016(02)03819-1","article-title":"Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma","volume":"55","author":"Denis","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib44","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/cncr.20069","article-title":"Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?","volume":"100","author":"Garden","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ijrobp.2003.12.002","article-title":"Radiation therapy for early-stage carcinoma of the oropharynx","volume":"59","author":"Selek","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib46","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1200\/JCO.1993.11.10.1873","article-title":"Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer","volume":"11","author":"Dassonville","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib47","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/S0959-8049(01)00280-5","article-title":"Radiochemotherapy of unresectable pharyngeal cancer","volume":"37","author":"Magn\u00e9","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib48","first-page":"1204","article-title":"Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer","volume":"7","author":"Shin","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib49","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1200\/JCO.2004.06.075","article-title":"Multicentric phase II study of erlotinib, an oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with recurrent or metastatic squamous cell cancer of the head and neck","volume":"22","author":"Soulieres","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2005.09.041_bib50","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjc.6600103","article-title":"Sequence-dependent effects of ZD1839 (\u2018Iressa\u2019) in combination with cytotoxic treatment in human head and neck cancer","volume":"86","author":"Magn\u00e9","year":"2002","journal-title":"Br J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301605027124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301605027124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T05:26:30Z","timestamp":1547875590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301605027124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0360301605027124"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2005.09.041","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}